RecruitingNCT05510622

Uterine Microbiome in Recurrent Pregnancy Loss

Reproductive Tract Microbiome in Women With Recurrent Pregnancy Loss


Sponsor

Mỹ Đức Hospital

Enrollment

100 participants

Start Date

Dec 12, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The female genital tract microbiome may reflect female reproductive health and may be related to pregnancy outcomes. Disturbances in this microbiome may be associated with adverse reproductive outcomes. The investigators hypothesize that the endometrial and vaginal microbiome composition in women with a history of recurrent pregnancy loss are different, compared with those in normal fertile women.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 38 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Vaginal swab and endometrial biopsy for people with recurrent pregnancy loss, not pregnant and vaginal microbiome. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years to 38 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVaginal swab and endometrial biopsy

A vaginal swab (DNA/RNA shield collection tube with swab - Zymo Research, CatNo R1107) and endometrial biopsy (Endobrush® - Lab CCD, Paris, France) will be obtained during 18th - 22nd day of the menstrual cycle.


Locations(2)

My Duc Hospital

Ho Chi Minh City, Ho Chi Minh City, Vietnam

My Duc Phu Nhuan Hospital

Ho Chi Minh City, Ho Chi Minh City, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05510622


Related Trials